All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IBI3014Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Unresectable Locally Advanced or Metastatic Solid Tumors

  • IBI305Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer

  • IBI334Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Advanced Solid Tumors

  • IBR854Phase 21 trial

    Imbioray (Hangzhou) Biomedicine Co., Ltd. · Renal Cell Carcinoma (RCC)

  • ICP-192Phase 21 trial

    Beijing InnoCare Pharma Tech Co., Ltd. · Intrahepatic Cholangiocarcinoma (ICC)

  • ICT01Phase 21 trial

    ImCheck Therapeutics, an Ipsen company · Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer

  • IDE161Phase 21 trial

    IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3

  • IDE397Phase 21 trial

    Amgen · MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors

  • IDE849Phase 21 trial

    IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3

  • IDP-001Phase 21 trial

    InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma

  • IDP-023Phase 21 trial

    Indapta Therapeutics, INC. · NHL, Multiple Myeloma, Blood Cancer

  • IDX-1197Phase 21 trial

    Idience Co., Ltd. · Gastric Cancer

  • ILKN421HPhase 21 trial

    iLeukon Therapeutics, Inc. · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • IMA401Phase 21 trial

    Immatics Biotechnologies GmbH · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult

  • IMA402Phase 21 trial

    Immatics Biotechnologies GmbH · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult

  • IMGN151Phase 21 trial

    AbbVie · Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer

  • ImofinostatABT-301, MPT0E028Phase 21 trial

    Anbogen Therapeutics, Inc. · Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC)

  • IMP1734Phase 21 trial

    Eikon Therapeutics · Advanced Solid Tumor

  • IMP9064Phase 21 trial

    Impact Therapeutics, Inc. · Solid Tumor, Advanced Solid Tumor

  • IMT-009Phase 21 trial

    Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer

  • INB301Phase 21 trial

    Yunnan Baiyao Group Co., Ltd. · Cancer Cachexia

  • INBRX-109Phase 21 trial

    Inhibrx Biosciences, Inc · Conventional Chondrosarcoma

  • INV-6452Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer

  • INV-8989Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC

  • INV-9956Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advanced Metastatic Castration Resistant Prostate Cancer

  • INX-315Phase 21 trial

    Incyclix Bio · Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor

  • IO-108Phase 21 trial

    Roche (Genentech) · Advanced Liver Cancers

  • IOV-3001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma

  • IOV-4001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer

  • IOV-5001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)

  • IPG1094Phase 21 trial

    Nanjing Immunophage Biotech Co., Ltd · Solid Tumor

  • IPH5201Phase 21 trial

    Innate Pharma · Non Small Cell Lung Cancer

  • IPN01194Phase 21 trial

    Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma

  • IPN01195Phase 21 trial

    Ipsen · Advanced Solid Tumor

  • IPN01203Phase 21 trial

    Ipsen · Advanced Solid Tumor, Metastatic Solid Tumor

  • IPN60300Phase 21 trial

    Ipsen · Locally Advanced Solid Tumor, Metastatic Solid Tumor

  • IPN60350Phase 21 trial

    Ipsen · Neoplasms, Neoplasm Metastasis, Neoplastic Processes

  • ISM3412Phase 21 trial

    InSilico Medicine Hong Kong Limited · Locally Advanced/Metastatic Solid Tumors

  • ISM6331Phase 21 trial

    InSilico Medicine Hong Kong Limited · Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor

  • IvaltinostatPhase 21 trial

    CG Pharmaceuticals, Inc · Metastatic Pancreatic Adenocarcinoma

  • JAB-2485Aurora A inhibitorPhase 21 trial

    Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC

  • JAB-30355Phase 21 trial

    Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors

  • JB100Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

  • JBI-778Phase 21 trial

    Jubilant Therapeutics Inc. · Brain Metastases From Solid Tumors, Leptomeningeal Disease, High Grade Glioma (HGG)

  • JK06Phase 21 trial

    Salubris Biotherapeutics Inc · Solid Tumor

  • JL15003InjectionPhase 21 trial

    Jecho Biopharmaceuticals Co., Ltd. · Recurrent Glioblastoma Multiforme(GBM)

  • JMBI-001Phase 21 trial

    Chengdu Anticancer Bioscience, Ltd. · Advance Solid Tumors, Lymphoma, Non-Hodgkin

  • JMT203Phase 21 trial

    Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia

  • JYP0015Phase 21 trial

    Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)

  • KAND567FractalkinePhase 21 trial

    Novakand Pharma AB · Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer

NewerPage 20 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.